About us.
Find out how we’re transforming ideas into impact at scale through the businesses we identify, back and grow.
Our portfolio.
Investors.
We have a proven track-record in backing and nurturing science and technology-based businesses to deliver a better future for people and planet.
Our impact.
Find out how we’re living our purpose and identifying, backing and growing businesses that contribute to a healthier, tech-enriched, sustainable future.
News & Events.
Open and close mobile menu
IP Group news
12 May 2026
Portfolio company Enterprise Therapeutics reports positive results from Phase 2 clinical trial for cystic fibrosis
IP Group plc
07 May 2026
Appointment of Michael Queen as Chair Designate
21 Apr 2026
Portfolio company First Light Fusion announces £25m successful first close of new round with investments from Starmaker One & UKAEA
Portfolio news
15 May 2026
Atisama Therapeutics advances RB042 into multiple ascending dose cohorts of Phase 1 trial and appoints Bernard Coulie as Chair of the Board
Atisama Therapeutics
Rage Bio becomes Atisama Therapeutics
13 May 2026
Mantle8 raises €31m in Series A funding to prove commercial viability of natural hydrogen production
Mantle8
11 Dec 2025
07 Nov 2025
18
Hybrid
17
Virtual
Event has passed
26
45 Gresham Street, London
